logo
SendQuick and pQCee Announce Strategic Partnership to Drive Quantum-Ready Solutions

SendQuick and pQCee Announce Strategic Partnership to Drive Quantum-Ready Solutions

Empowering Over 1,000 Enterprises and SMEs with Post-Quantum Messaging and Authentication Capabilities
'By joining forces, we are enabling organizations to adopt quantum-safe strategies that reinforce their trust and security in messaging and authentication.'— Mr JS Wong, CEO of SendQuick Pte Ltd
SINGAPORE, April 28, 2025 / EINPresswire.com / -- SendQuick Pte Ltd, a trusted provider of messaging and authentication platforms and pQCee Pte Ltd, a leader in cutting-edge post-quantum cybersecurity solutions, are proud to announce a groundbreaking partnership to revolutionize enterprise security. The two companies signed a Memorandum of Understanding (MOU) on 21 April 2025 to formalize this collaboration, paving the way for enhanced, quantum-ready solutions for businesses.
The partnership combines pQCee's advanced post-quantum products, including quantum-safe encryption and secure key management, with SendQuick's widely adopted messaging and authentication solutions. With a customer base exceeding 1,000 enterprises and SMEs, SendQuick's clients will now have access to integrated solutions that prepare them for a quantum-secure future.
'This partnership with pQCee marks an important milestone for our company and customers. By joining forces, we are enabling organizations to adopt quantum-safe strategies that reinforce their trust and security in messaging and authentication,' said Mr JS Wong, CEO of SendQuick Pte Ltd. 'The quantum threat is real and SendQuick will lead the way in helping our customer mitigate and prevent such attacks'.
Dr Teik Guan Tan, CEO of pQCee added, 'At pQCee, we are committed to staying ahead of the cybersecurity curve, and our partnership with SendQuick reflects this dedication. Together, we will empower businesses with robust, future-proof solutions that seamlessly integrate quantum-safe technologies into their everyday operations.'
The collaboration will provide SendQuick's customers with a pathway to adopt post-quantum security technologies, ensuring their sensitive data and communications are protected against emerging threats posed by advances in quantum computing. By integrating post-quantum algorithms and secure messaging platforms, this partnership offers unparalleled end-to-end protection.
With this strategic integration, SendQuick and pQCee are set to redefine enterprise cybersecurity, offering scalable, quantum-ready solutions that safeguard data integrity and privacy for years to come.
About SendQuick Pte Ltd:
SendQuick is a leading provider of communications platforms specializing in enterprise mobile messaging, IT alerts, and secure remote access solutions with Multi-Factor Authentication (MFA). SendQuick serves businesses across various industries with award-winning solutions that enhance operational security, efficiency, and communications.
About pQCee Pte Ltd:
pQCee is a leader in post-quantum cryptography solutions, dedicated to developing advanced security tools to protect organizations against future cyber threats. With a team of world-class researchers and engineers, pQCee delivers scalable, quantum-resistant encryption solutions designed to safeguard critical data and digital assets.
For media inquiries, please contact:
Contact Information
SendQuick Pte Ltd
Andy Hun
[email protected]
pQCee Pte Ltd
Dr TAN Teik Guan
[email protected]
Andy Hun
SendQuick Pte Ltd
email us here
Visit us on social media:
Facebook
LinkedIn
YouTube
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Zoetis Inc. (ZTS): A Bull Case Theory
Zoetis Inc. (ZTS): A Bull Case Theory

Yahoo

time30-05-2025

  • Yahoo

Zoetis Inc. (ZTS): A Bull Case Theory

We came across a bullish thesis on Zoetis Inc. (ZTS) on Best Anchor Stocks' Substack. In this article, we will summarize the bulls' thesis on ZTS. Zoetis Inc. (ZTS)'s share was trading at $161.97 as of 22nd May. ZTS's trailing and forward P/E were 29.08 and 26.18 respectively according to Yahoo Finance. Syda Productions/ Zoetis (ZTS) reported mixed earnings that triggered a 5% sell-off, though the stock partially recovered the next day. While headline numbers were not disastrous, underlying concerns justified the reaction. Operational revenue grew 9%, but reported revenue rose just 1% due to FX headwinds and the recent divestiture of the low-margin MFA business, which ironically improved margins—gross margin expanded by 140 bps and operating margin by 150 bps. The company's capital return strategy remains robust, with buybacks accounting for 83% of free cash flow over the past year and a 2.4% year-over-year reduction in share count, boosting EPS growth above net income. Despite this, organic growth decelerated slightly, largely due to weaker-than-expected adoption of Librela, Zoetis' osteoarthritis pain monoclonal antibody. Though Librela posted 17% U.S. growth, management acknowledged slow uptake from poor awareness and macro pressures, leading to a downward revision of operational net income guidance. This is troubling, given Librela's previously expected outsized contribution to future growth and margins. However, Zoetis unveiled a new, long-acting OA pain MAB in the pipeline—administered quarterly, with fewer side effects and a distinct brand—which could reset the narrative if approved in late 2025. Meanwhile, core franchises in parasiticides and dermatology (Simparica and Apoquel) continue to post double-digit growth despite rising competition. The shift toward retail, now 21% of U.S. sales, enhances reach but slightly dilutes the vet-driven moat. Ultimately, while near-term execution challenges around Librela weigh on sentiment, Zoetis' market leadership, innovation pipeline, and structural tailwinds support a favorable long-term outlook. We have previously covered Zoetis Inc. (ZTS) in December 2024 wherein we summarized a bull thesis by Business Model Mastery on Substack. The author highlighted Zoetis (ZTS) as a top play on the booming pet care market. Since then, the company has delivered strong Q3 results, led by blockbuster osteoarthritis and dermatology treatments, retail expansion, and global growth. With rising chronic care demand and diagnostics adoption, ZTS remains a long-term compounder. Zoetis Inc. (ZTS) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 76 hedge fund portfolios held ZTS at the end of the fourth quarter which was 62 in the previous quarter. While we acknowledge the risk and potential of ZTS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than ZTS but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey.

Mark Farrah Associates Analyzed the 2024 Medicare Supplement Market
Mark Farrah Associates Analyzed the 2024 Medicare Supplement Market

Yahoo

time28-05-2025

  • Yahoo

Mark Farrah Associates Analyzed the 2024 Medicare Supplement Market

CANONSBURG, Pa., May 28, 2025--(BUSINESS WIRE)--In the latest Healthcare Business Strategy report, Mark Farrah Associates (MFA), provided an overview of the 2024 Medicare Supplement market with insights about competitive positioning and standardized plan type preferences. Medicare Supplement plans, also known as Medigap or Med Supp plans, covered over 13.54 million seniors as of December 31, 2024, representing a year-over-year enrollment decline of 0.3%. Many leading managed care organizations, Blues plans, regional plans, and multiline carriers compete in the Medicare Supplement space. Highlights Include: MFA's assessment of standardized plan type preferences for 2024 found Plan G remained the most popular plan type, enrolling approximately 5.7 million members. Approximately 4.5 million Med Supp members were enrolled in Plan F and accounted for 30% of the market in 2024. Medicare Supplement plans collectively earned approximately $37 billion in premiums and paid out $31.3 billion in claims during 2024. The aggregate loss ratio (incurred claims as a percentage of earned premiums) was 84.4% as of December 2024. UnitedHealth continued to lead in this segment with 4.3 million members and covered 32% of the market as of December 31, 2024. To read the FREE full text of "Medicare Supplement Enrollment Down Slightly in 2024", visit the MFA Briefs on Mark Farrah Associates' website. You can also follow us on LinkedIn. About Med Supp Market Data Med Supp Market Data, a Health Coverage Portal option offered by Mark Farrah Associates, presents the latest market share and financial performance data for Medicare Supplement plans. The product includes state-by-state membership, premiums, claims and loss ratios for plans nationwide. Online tables also include claims contacts as reported in the financial statements as filed with the National Association of Insurance Commissioners (NAIC). California managed care plans do not file financial statements with the NAIC and are not included in this analysis. For more information about Med Supp Market Data, please visit our website ( or call 724.338.4100. About Mark Farrah Associates (MFA) MFA is a leading data aggregator and publisher providing health plan market data and analysis tools for the healthcare industry. Committed to simplifying analysis of health insurance business, our products include: Health Coverage Portal™, Medicare Business Online™, Medicare Benefits Analyzer™, County Health Coverage™, Health Plans USA™ and 5500 Employer Health Plus. View source version on Contacts Mark Farrah AssociatesAnn Marie Wolfe, amwolfe@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Mark Farrah Associates Analyzed the 2024 Medicare Supplement Market
Mark Farrah Associates Analyzed the 2024 Medicare Supplement Market

Business Wire

time28-05-2025

  • Business Wire

Mark Farrah Associates Analyzed the 2024 Medicare Supplement Market

CANONSBURG, Pa.--(BUSINESS WIRE)--In the latest Healthcare Business Strategy report, Mark Farrah Associates (MFA), provided an overview of the 2024 Medicare Supplement market with insights about competitive positioning and standardized plan type preferences. Medicare Supplement plans, also known as Medigap or Med Supp plans, covered over 13.54 million seniors as of December 31, 2024, representing a year-over-year enrollment decline of 0.3%. Many leading managed care organizations, Blues plans, regional plans, and multiline carriers compete in the Medicare Supplement space. Highlights Include: MFA's assessment of standardized plan type preferences for 2024 found Plan G remained the most popular plan type, enrolling approximately 5.7 million members. Approximately 4.5 million Med Supp members were enrolled in Plan F and accounted for 30% of the market in 2024. Medicare Supplement plans collectively earned approximately $37 billion in premiums and paid out $31.3 billion in claims during 2024. The aggregate loss ratio (incurred claims as a percentage of earned premiums) was 84.4% as of December 2024. UnitedHealth continued to lead in this segment with 4.3 million members and covered 32% of the market as of December 31, 2024. To read the FREE full text of " Medicare Supplement Enrollment Down Slightly in 2024", visit the MFA Briefs on Mark Farrah Associates' website. You can also follow us on LinkedIn. About Med Supp Market Data Med Supp Market Data, a Health Coverage Portal option offered by Mark Farrah Associates, presents the latest market share and financial performance data for Medicare Supplement plans. The product includes state-by-state membership, premiums, claims and loss ratios for plans nationwide. Online tables also include claims contacts as reported in the financial statements as filed with the National Association of Insurance Commissioners (NAIC). California managed care plans do not file financial statements with the NAIC and are not included in this analysis. For more information about Med Supp Market Data, please visit our website ( or call 724.338.4100. MFA is a leading data aggregator and publisher providing health plan market data and analysis tools for the healthcare industry. Committed to simplifying analysis of health insurance business, our products include: Health Coverage Portal™, Medicare Business Online™, Medicare Benefits Analyzer™, County Health Coverage™, Health Plans USA™ and 5500 Employer Health Plus.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store